|
市場調査レポート
商品コード
1554259
アブレーション装置市場規模、シェア、成長分析：製品別、用途別、最終用途別、地域別 - 産業予測、2024年～2031年Ablation Devices Market Size, Share, Growth Analysis, By Product, By Application, By End use, By Region - Industry Forecast 2024-2031 |
||||||
|
|||||||
| アブレーション装置市場規模、シェア、成長分析：製品別、用途別、最終用途別、地域別 - 産業予測、2024年～2031年 |
|
出版日: 2024年09月07日
発行: SkyQuest
ページ情報: 英文 265 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
アブレーション装置の世界市場規模は、2022年に79億2,000万米ドルと評価され、2023年の86億米ドルから2031年には179億2,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.5％で成長する見通しです。
外科技術は、ヘルスケア分野における大幅な進歩に伴い、世界的に大きな進化を遂げています。こうした進歩は、最先端のスクリーニング、診断、治療技術の採用から、術後の不快感を最小限に抑える戦略の導入まで多岐にわたる。この分野における顕著な発展は、低侵襲手術の台頭であり、その利点からますます支持されるようになっています。高齢者人口が増加し、慢性疾患が複雑化するにつれ、患者はより負担の少ない治療法を求めるようになっています。低侵襲手術には、痛みの軽減、入院期間の短縮、回復時間の短縮といった利点があります。低侵襲手術の重要な点はアブレーションであり、気化、凍結、放射線、機械的侵食などの方法によって人間の臓器から生体物質を除去する技術です。医療現場では通常、小さな腫瘍や汚染された組織を最小限の侵襲で切除するためにアブレーションが用いられます。化学的アブレーションや高周波アブレーションなどの技術も、影響を受けた生体組織を標的として切除するために利用されます。アブレーションの人気は、従来の開腹手術に比べて侵襲が少なく、腫瘍や組織の除去により快適な選択肢を提供できることから、最近急上昇しています。がんや心血管系疾患を含む慢性疾患の増加により、アブレーション装置の需要は拡大すると予想されます。
目次
イントロダクション
- 調査の目的
- 定義
- 市場範囲
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模予測
- 市場の想定と制限
エグゼクティブサマリー
- 市場概要見通し
- 供給需要動向分析
- セグメント別機会分析
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- ポーターの分析
主な市場の考察
- 市場の成功要因
- バリューチェーン分析
- 主な投資機会
- 市場魅力度指数
- エコシステムマッピング
- PEST分析
- ポーターのファイブフォース分析
- サプライチェーン分析
- エコシステムの範囲：親市場
- 払い戻しシナリオ
- 価格動向分析
- 貿易分析
アブレーション装置市場：製品別
- 市場概要
- 無線周波数デバイス
- レーザー/光アブレーター
- エキシマレーザーアブレーター
- コールドレーザーアブレーター
- 超音波装置
- 高強度焦点式超音波アブレーター
- 体外衝撃波結石破砕システム
- 磁気共鳴誘導集束超音波アブレーション装置
- 凍結アブレーション装置
- 組織接触プローブ
- 組織スプレープローブ
- 表皮および皮下凍結融解装置
- 電気アブレーター
- アルゴンプラズマ/ビーム凝固装置
- 不可逆的エレクトロポレーションアブレーター
- マイクロ波アブレーター
- 水熱アブレーター
- その他
アブレーション装置市場：用途別
- 市場概要
- 心臓血管疾患の治療
- 美容整形外科
- 整形外科治療
- がん治療
- 肝臓がん
- 腎臓がん
- 前立腺がん
- 肺がん
- 骨転移
- 乳がん
- 泌尿器科治療
- 婦人科治療
- 痛みの管理
- 眼科治療
アブレーション装置市場：最終用途別
- 市場概要
- 病院、外科センター、アブレーションセンター
- 外来手術センター
- メディカルスパ＆エステティッククリニック
- その他の最終用途
アブレーション装置市場：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州地域
- アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主な市場企業が採用した戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Johnson & Johnson（US）
- Medtronic（Ireland）
- Boston Scientific Corporation（US）
- Abbott（US）
- AtriCure, Inc.（US）
- AngioDynamics（US）
- ConMed Corporation（US）
- Olympus Corporation（Japan）
- Smith+Nephew（UK）
- Stryker（US）
- Cynosure Lutronic（US）
- BioVentus（US）
- Merit Medical Systems（US）
- Canyon Medical Inc.（US）
- Arthrex, Inc.（US）
- IceCure Medical（Israel）
- Minimax Medical Holding Group（China）
- CardioFocus（US）
- EDAP TMS（France）
- Mermaid Medical（Denmark）
- Monteris（Canada）
- SonaBlate Corp.（US）
- Eco Medical（US）
- Surgnova（France）
Global Ablation Devices Market size was valued at USD 7.92 billion in 2022 and is poised to grow from USD 8.60 billion in 2023 to USD 17.92 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).
Surgical techniques have undergone significant evolution globally, with substantial advancements in the healthcare sector. These advancements range from adopting cutting-edge screening, diagnostic, and treatment technologies to implementing strategies that minimize post-surgical discomfort. A notable development in this area is the rise of minimally invasive surgery, which has become increasingly favored due to its benefits. As the senior population grows and chronic conditions become more complex, patients are seeking less disruptive treatment options. Minimally invasive surgery offers advantages such as reduced pain, shorter hospital stays, and faster recovery times. A key aspect of minimally invasive procedures is ablation, a technique used to remove biological material from human organs through methods like vaporization, freezing, radiation, or mechanical erosion. In medical practice, ablation is typically employed to excise small tumors or contaminated tissues with minimal invasiveness. Techniques such as chemical ablation and radiofrequency ablation are also utilized to target and eliminate affected biological tissues. The popularity of ablation has surged recently due to its less intrusive nature compared to traditional open surgeries, offering a more comfortable alternative for tumor and tissue removal. With the increasing incidence of chronic diseases, including cancer and cardiovascular issues, the demand for ablation devices is expected to grow.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Ablation Devices Market Segmental Analysis
The global Ablation Devices market is segmented based on product, application, end use, and region. Based on product, the market is segmented into Radiofrequency Devices, Laser/Light Ablators, Ultrasound Devices, Cryoablation Devices, Electric Ablators, Microwave Ablators, Hydrothermal Ablators and Others. Based on application, the market is segmented into Cardiovascular Disease Treatment, Cosmetic/Aesthetic Surgery, Orthopaedic Treatment, Cancer Treatment, Urological Treatment, Gynaecological Treatment, Pain Managment, and Ophthalmological Treatment. Based on end use, the market is segmented into Hospitals, Surgical Centers, And Ablation Centers, Ambulatory Surgical Centers, Medical Spas & Aesthetic Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and MEA.
Drivers of the Global Ablation Devices Market
A significant driver of market growth is the increasing patient preference for minimally invasive procedures over traditional open surgeries. The popularity of minimally invasive treatments has surged due to their advantages, including shorter hospital stays, quicker recovery, and reduced discomfort compared to conventional methods. Additionally, the growing prevalence of atrial fibrillation among the general population is expected to drive the demand for cardiac ablation procedures. Minimally invasive ablation techniques for atrial fibrillation offer high effectiveness, lower risk, and greater patient convenience. Consequently, the growing adoption of less invasive treatment options and advancements in ablation devices are anticipated to significantly boost the ablation devices market in the coming years.
Restraints in the Global Ablation Devices Market
A notable limitation in the market is the absence of effective conventional first-line treatments for conditions such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic disorders. Traditional therapies, including surgery, chemotherapy, and radiation, remain popular due to widespread public familiarity and acceptance. In particular, there is low adoption of newer treatment options in developing countries, coupled with oncologists' hesitation to move away from established methods. This reluctance to embrace advanced treatments impedes the growth of newer therapeutic approaches in these areas.
Market Trends of the Global Ablation Devices Market
Emerging markets in Asia-Pacific, Africa, and Latin America are anticipated to become increasingly attractive due to advancements in ablation technologies, rising demand for minimally invasive treatments, and growing disposable incomes. Additionally, these regions benefit from a substantial population with undiagnosed conditions, rapid urbanization leading to higher chronic disease rates, increased awareness of prostate cancer, and improved government funding for healthcare. These factors are expected to drive market growth and expand opportunities for ablation technologies in these regions.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors of The Market
- Value Chain Analysis
- Top Investment Pockets
- Market Attractive Index
- Ecosystem Mapping
- Pest Analysis
- Porter's Five Forces Analysis
- Supply chain analysis
- Ecosystem coverage: parent market
- Reimbursement scenario
- Pricing trend analysis
- Trade Analysis
Global Ablation Devices Market by Product
- Market Overview
- Radiofrequency Devices
- Laser/Light Ablators
- Excimer laser ablators
- Cold laser ablators
- Ultrasound Devices
- High-intensity focused ultrasound ablators
- Extracorporeal shockwave lithotripsy systems
- Magnetic resonance-guided focused ultrasound ablators
- Cryoablation Devices
- Tissue contacts probes
- Tissue spray probes
- Epidermal & subcutaneous cryoablation devices
- Electric Ablators
- Argon plasma/beam coagulators
- Irreversible electroporation ablators
- Microwave Ablators
- Hydrothermal Ablators
- Others
Global Ablation Devices Market by Application
- Market Overview
- Cardiovascular Disease Treatment
- Cosmetic/Aesthetic Surgery
- Orthopaedic Treatment
- Cancer Treatment
- Liver Cancer
- Kidney Cancer
- Prostate Cancer
- Lung Cancer
- Bone Metastasis
- Breast Cancer
- Urological Treatment
- Gynaecological Treatment
- Pain Managment
- Ophthalmological Treatment
Global Ablation Devices Market by End Use
- Market Overview
- Hospitals, Surgical Centers, And Ablation Centers
- Ambulatory Surgical Centers
- Medical Spas & Aesthetic Clinics
- Other End Users
Global Ablation Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ConMed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith+Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cynosure Lutronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioVentus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canyon Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arthrex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IceCure Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Minimax Medical Holding Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardioFocus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EDAP TMS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mermaid Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Monteris (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SonaBlate Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eco Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Surgnova (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
